ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Atlantic Coastal Acquisition Corporation II

Atlantic Coastal Acquisition Corporation II (ACAB)

5.77
0.00
( 0.00% )
Updated: 18:00:00

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
5.77
Bid
6.32
Ask
6.40
Volume
-
0.00 Day's Range 0.00
5.75 52 Week Range 13.20
Market Cap
Previous Close
5.77
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
10,695
Shares Outstanding
8,167,390
Dividend Yield
-
PE Ratio
16.70
Earnings Per Share (EPS)
0.35
Revenue
-
Net Profit
2.82M

About Atlantic Coastal Acquisition Corporation II

Atlantic Coastal Acquisition Corp II is a blank check company. Atlantic Coastal Acquisition Corp II is a blank check company.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Atlantic Coastal Acquisition Corporation II is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ACAB. The last closing price for Atlantic Coastal Acquisi... was US$5.77. Over the last year, Atlantic Coastal Acquisi... shares have traded in a share price range of US$ 5.75 to US$ 13.20.

Atlantic Coastal Acquisi... currently has 8,167,390 shares outstanding. The market capitalization of Atlantic Coastal Acquisi... is US$47.13 million. Atlantic Coastal Acquisi... has a price to earnings ratio (PE ratio) of 16.70.

ACAB Latest News

Atlantic Coastal Acquisition Corp. II Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Atlantic Coastal Acquisition Corp. II Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q PR Newswire NEW YORK, June 13, 2024 NEW YORK, June 13, 2024...

Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II

WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Abpro Corporation (“Abpro”), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening...

Atlantic Coastal Acquisition Corp. II Announces Extension of Business Combination Period and Additional Contribution to Trust Account

Atlantic Coastal Acquisition Corp. II Announces Extension of Business Combination Period and Additional Contribution to Trust Account PR Newswire NEW YORK, Oct. 18, 2023 NEW YORK, Oct. 18, 2023...

IMPORTANT: Atlantic Coastal Acquisition Corp. Files Definitive Proxy Statement in Connection with Plan to Extend the Amount of Time the Company has to Consummate a Business Combination

IMPORTANT: Atlantic Coastal Acquisition Corp. Files Definitive Proxy Statement in Connection with Plan to Extend the Amount of Time the Company has to Consummate a Business Combination PR...

Atlantic Coastal Acquisition Corp. Announces Plans to Extend Deadline to Complete Initial Business Combination.

Atlantic Coastal Acquisition Corp. Announces Plans to Extend Deadline to Complete Initial Business Combination. PR Newswire NEW YORK, Aug. 25, 2023 The Company Also Received a Notice of...

Atlantic Coastal Acquisition Corp. Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination

Atlantic Coastal Acquisition Corp. Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination PR Newswire NEW YORK, Aug. 18, 2023 NEW YORK, Aug. 18, 2023 /PRNewswire/...

Atlantic Coastal Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Atlantic Coastal Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q PR Newswire NEW YORK, May 30, 2023 NEW YORK, May 30, 2023...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1005.775.775.7700CS
4-5.6573-49.506882640711.4273135.75222798.94153604CS
12-5.46-48.619768477311.23135.75106959.70524776CS
26-5.27-47.735507246411.0413.25.75799310.21383436CS
52-4.83-45.566037735810.613.25.75520810.31950317CS
156-4.15-41.83467741949.9213.25.753212410.23878784CS
260-4.15-41.83467741949.9213.25.753212410.23878784CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTNTCheetah Net Supply Chain Service Inc
US$ 5.4101
(189.31%)
106.71M
ZJKZJK Industrial Company Ltd
US$ 14.5599
(129.65%)
19.85M
GWAVGreenwave Technology Solutions Inc
US$ 0.62765
(71.96%)
371.81M
JANXJanux Therapeutics Inc
US$ 63.27
(57.47%)
5.21M
JYDJayud Global Logistics Ltd
US$ 1.032
(54.01%)
8.91M
REVBRevelation Biosciences Inc
US$ 0.551
(-41.99%)
3.69M
OMEXOdyssey Marine Exploration Inc
US$ 0.4876
(-34.57%)
3.51M
STSSSharps Technology Inc
US$ 2.26
(-32.61%)
333.93k
GELSGelteq Ltd
US$ 2.7064
(-29.16%)
237.59k
CYCNCyclerion Therapeutics Inc
US$ 1.69
(-27.78%)
247.01k
GWAVGreenwave Technology Solutions Inc
US$ 0.62765
(71.96%)
371.81M
SMCISuper Micro Computer Inc
US$ 41.38
(-1.48%)
162.13M
CTNTCheetah Net Supply Chain Service Inc
US$ 5.4101
(189.31%)
106.71M
CHRSCoherus BioSciences Inc
US$ 1.985
(44.89%)
100.02M
CTORCitius Oncology Inc
US$ 1.47
(44.12%)
97.71M